Tocilizumab (Anti-Human IL6R) is a neutralizing antibody against human interleukin-6 receptor (IL-6R) that blocks the binding of IL-6 to IL-6R, thereby inhibiting both classical and trans signaling. It can be used to study rheumatoid arthritis and has been suggested as a possible drug for the treatment of severe COVID-19.
Molecular Weight:
148 kDa
Purity:
99.50%
CAS Number:
[375823-41-9]
Target:
Interleukin
T9911
* VAT and and shipping costs not included. Errors and price changes excepted
